JUUL Reaches $438.5 Million Settlement with 34 States Over Marketing Practices

Sep.08.2022
JUUL Reaches $438.5 Million Settlement with 34 States Over Marketing Practices
JUUL reaches $438.5 million settlement with 34 states over marketing and sales practices, including strict marketing and sales restrictions.

On September 7th, Attorney General Leslie Rutledge of Arkansas announced a $438.5 million settlement agreement between JUUL and 34 states and territories, resolving a two-year investigation into the electronic cigarette manufacturer's marketing and sales practices. In addition to financial terms, the settlement will force JUUL to comply with a series of strict injunction terms limiting its marketing and sales practices. Arkansas will receive $13,553,391.88 over the course of five years.


Justice Department Chief Rattlitch stated, "Companies like JUUL spreading misinformation and encouraging young people to purchase e-cigarette products are the cause of this epidemic, which continues to be a prevalent problem in our schools and communities. After two years of investigation, I am holding JUUL accountable for their actions and ensuring that they will comply with the law in the future, so that Arkansans are protected from fraudulent business practices.


Until recently, JUUL was the dominant player in the electronic cigarette market. Multiple state investigations have revealed that JUUL intentionally marketed their e-cigarettes to attract young people, despite it being illegal and unhealthy for minors to use their products. The investigation found that JUUL callously marketed to underage users through events, ads featuring trendy young models, social media posts, and free samples. They promoted a technology-focused, sleek design that could easily be hidden and sold their products in flavors that were attractive to underage users. JUUL even tweaked the chemical composition of its products to reduce the harshness of the vapor on young and inexperienced users' throats, all to retain their youthful customer base.


Further investigation has revealed that JUUL's original packaging is misleading, as it does not clearly disclose the presence of nicotine and implies a lower concentration than is actually contained. Consumers are also misled into believing that consuming one JUUL pod is equivalent to smoking one pack of combustible cigarettes. The company also falsely claims that its product is a smoking cessation device, making such a statement without FDA approval.


Each state is finalizing and implementing a settlement agreement, which is expected to take approximately 3-4 weeks. A total of $438.5 million will be paid over the course of 6-10 years, with the payment amount increasing the longer the company takes to pay. If JUUL chooses to extend the payment period to ten years, the final settlement amount will reach $476.6 million. The financial and injunction terms exceed any previous agreements reached by JUUL with the states thus far.


As part of a settlement agreement, JUUL has agreed to avoid:


The Youth Marketing Educational Scholarship Program targets individuals under the age of 35 in any marketing campaign. The use of cartoons and paid product placements is permitted to sell branded goods. Landing pages can provide access to websites without age verification for fragrances not approved by the FDA. Statements about nicotine not approved by the FDA and misleading statements about nicotine content are not allowed. Sponsorships and naming rights cannot be used unless 85% of the audience is adults. Advertising is restricted in stores, online, and on public transportation and social media, except for recommendations for individuals over 35 without health claims. The agreement also includes sales and distribution restrictions, such as product display and access locations in stores, online sales restrictions, retail sales restrictions, age verification for all sales, and retail compliance inspections.


An investigation led by Connecticut, Texas, and Oregon has resulted in a joint agreement signed by Alabama, Arkansas, Connecticut, Delaware, Georgia, Hawaii, Idaho, Indiana, Kansas, Kentucky, Maryland, Maine, Mississippi, Montana, North Dakota, Nebraska, New Hampshire, New Jersey, Nevada, Ohio, Oklahoma, Oregon, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Vermont, Wisconsin, and Wyoming.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the content. The compilation of this article is only intended for industry communication and research purposes.


Due to limitations in the compiler's abilities, the translated article may not fully express the same meaning as the original. For accuracy, please refer to the original text.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of compiled information belongs to the original media and author. Please contact for deletion in case of infringement.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11
India Tobacco Board urges Finance Minister Nirmala Sitharaman to revisit cigarette duty hike
India Tobacco Board urges Finance Minister Nirmala Sitharaman to revisit cigarette duty hike
The Tobacco Board, under the administrative control of India’s Department of Commerce, has written to Finance Minister Nirmala Sitharaman (Nirmala Sitharaman) flagging the adverse impact of an “unprecedented” increase in cigarette excise duties on the industry and on millions of farmers and workers, and urging a revision of duty rates.
Feb.11 by 2FIRSTS.ai
Belarus Official Says Full Vape Ban Is Not Advisable Due to Supply Risks From Russia
Belarus Official Says Full Vape Ban Is Not Advisable Due to Supply Risks From Russia
A Belarusian Interior Ministry official said on March 18 at a press conference on preventing dependence on electronic smoking systems that a full ban on vapes is not appropriate in Belarus at this stage.
Mar.19 by 2FIRSTS.ai
Spain’s PSOE files motion to curb vaping and nicotine pouches, restricting sales channels and banning online sales
Spain’s PSOE files motion to curb vaping and nicotine pouches, restricting sales channels and banning online sales
Spain’s Socialist Party (PSOE) has registered a non-legislative motion (PNL) in Congress seeking to curb the use of vapes and nicotine pouches by restricting sales to authorised channels and banning sales online and in non-specialist shops. The proposal says the current “lack of control” in commercialisation facilitates tax evasion and breaches existing health and environmental rules.
Mar.03 by 2FIRSTS.ai
Pennsylvania Lawmaker Seeks to Keep Vape Shops Away From Schools
Pennsylvania Lawmaker Seeks to Keep Vape Shops Away From Schools
A Pennsylvania lawmaker is seeking legislation that would require newly licensed vape shops to be located at least 1,000 feet away from K-12 schools in the state. The proposal was put forward by State Representative Chris Pielli.
Mar.11 by 2FIRSTS.ai
Special Report | PLONQ Expands in China With New Shenzhen Hub to Accelerate R&D and Partnerships
Special Report | PLONQ Expands in China With New Shenzhen Hub to Accelerate R&D and Partnerships
On March 27, 2026, PLONQ officially opened its upgraded Shenzhen office, reinforcing its long-term commitment to China and marking a new phase of growth. As a leading vape brand in Russia, PLONQ is expanding into new product categories while strengthening R&D, engineering collaboration, and partnerships with Chinese companies. The Shenzhen office will accelerate product development, enhance cooperation with technology and manufacturing partners, and support future growth initiatives.
Apr.01